AstraZeneca India Private Limited (AZIPL) has repositioned its Global Technology Centre (GTC) to focus on driving increased innovation, resulting in a rebrand of the centre to Global Innovation and Technology Centre (GITC).

The Chennai centre has played a key role in driving productivity, simplification, technology delivery and innovation across AstraZeneca’s business and supports life-changing medicines delivered to patients worldwide. The rebranding marks the centre’s evolution of capabilities, commitment to driving innovation and moving the company towards a digitally-enabled future.

Cindy Hoots, Chief Digital Office and CIO, AstraZeneca, said, “Our centre in Chennai continues to play a strategic role in our digital transformation, working on visualisation, data and analytics, hyperautomation, XR/VR Capabilities, among other areas. These technologies and innovations play a key role in helping us to advance our science, anticipate patient needs, and work seamlessly across our organisation.”

Siva Padmanabhan, MD, AZIPL, said, “With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country. The strong collaboration we have been able to build between industry, academia and the government has helped us in our pursuit of enabling smart capabilities at scale across the company’s value chain. Our GITC aims to bring the best of technology, innovation and people to the forefront, to address the ever-evolving healthcare and technology landscape."